rs34819316

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 1P and 13B. PP3BP4_StrongBP6BS1BS2

The NM_000338.3(SLC12A1):​c.347G>A​(p.Arg116His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00445 in 1,613,608 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 30 hom. )

Consequence

SLC12A1
NM_000338.3 missense

Scores

9
6
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:6

Conservation

PhyloP100: 10.0

Publications

16 publications found
Variant links:
Genes affected
SLC12A1 (HGNC:10910): (solute carrier family 12 member 1) This gene encodes a kidney-specific sodium-potassium-chloride cotransporter that is expressed on the luminal membrane of renal epithelial cells of the thick ascending limb of Henle's loop and the macula densa. It plays a key role in concentrating urine and accounts for most of the NaCl resorption. It is sensitive to such diuretics as furosemide and bumetanide. Some Bartter-like syndromes result from defects in this gene. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their biological validity in humans has not been experimentally proven.[provided by RefSeq, May 2010]
SLC12A1 Gene-Disease associations (from GenCC):
  • antenatal Bartter syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Bartter disease type 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 8: BayesDel_addAF, BayesDel_noAF, Cadd, Dann, Eigen, phyloP100way_vertebrate, REVEL, REVEL [when AlphaMissense, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.02112645).
BP6
Variant 15-48208066-G-A is Benign according to our data. Variant chr15-48208066-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 445491.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00324 (494/152254) while in subpopulation AMR AF = 0.00576 (88/15290). AF 95% confidence interval is 0.00478. There are 0 homozygotes in GnomAd4. There are 206 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 30 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000338.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC12A1
NM_000338.3
MANE Select
c.347G>Ap.Arg116His
missense
Exon 2 of 27NP_000329.2Q13621-1
SLC12A1
NM_001184832.2
c.347G>Ap.Arg116His
missense
Exon 2 of 27NP_001171761.1Q13621-3
SLC12A1
NM_001384136.1
c.347G>Ap.Arg116His
missense
Exon 2 of 27NP_001371065.1A0A8I5KSK6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC12A1
ENST00000380993.8
TSL:5 MANE Select
c.347G>Ap.Arg116His
missense
Exon 2 of 27ENSP00000370381.3Q13621-1
SLC12A1
ENST00000330289.10
TSL:1
c.347G>Ap.Arg116His
missense
Exon 1 of 9ENSP00000331550.6Q8IUN5
SLC12A1
ENST00000646012.1
c.347G>Ap.Arg116His
missense
Exon 2 of 28ENSP00000495813.1A0A2R8Y6V7

Frequencies

GnomAD3 genomes
AF:
0.00325
AC:
494
AN:
152136
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00576
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00467
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.00346
AC:
861
AN:
248770
AF XY:
0.00351
show subpopulations
Gnomad AFR exome
AF:
0.000800
Gnomad AMR exome
AF:
0.00454
Gnomad ASJ exome
AF:
0.00469
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00190
Gnomad NFE exome
AF:
0.00514
Gnomad OTH exome
AF:
0.00492
GnomAD4 exome
AF:
0.00457
AC:
6680
AN:
1461354
Hom.:
30
Cov.:
31
AF XY:
0.00443
AC XY:
3219
AN XY:
726902
show subpopulations
African (AFR)
AF:
0.000777
AC:
26
AN:
33480
American (AMR)
AF:
0.00501
AC:
224
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00483
AC:
126
AN:
26114
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39694
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86174
European-Finnish (FIN)
AF:
0.00206
AC:
110
AN:
53380
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5768
European-Non Finnish (NFE)
AF:
0.00536
AC:
5954
AN:
1111662
Other (OTH)
AF:
0.00379
AC:
229
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
360
720
1080
1440
1800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00324
AC:
494
AN:
152254
Hom.:
0
Cov.:
32
AF XY:
0.00277
AC XY:
206
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.00116
AC:
48
AN:
41554
American (AMR)
AF:
0.00576
AC:
88
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.000943
AC:
10
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00467
AC:
318
AN:
68024
Other (OTH)
AF:
0.00804
AC:
17
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00465
Hom.:
9
Bravo
AF:
0.00398
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00547
AC:
47
ExAC
AF:
0.00334
AC:
405
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00556
EpiControl
AF:
0.00498

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
2
not provided (4)
1
1
1
Bartter disease type 1 (3)
-
-
2
not specified (2)
-
-
1
SLC12A1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Pathogenic
0.49
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.83
D
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.93
D
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.021
T
MetaSVM
Pathogenic
0.88
D
MutationAssessor
Uncertain
2.6
M
PhyloP100
10
PrimateAI
Uncertain
0.60
T
PROVEAN
Uncertain
-2.7
D
REVEL
Pathogenic
0.85
Sift
Benign
0.044
D
Sift4G
Uncertain
0.045
D
Polyphen
0.99
D
Vest4
0.84
MVP
0.95
MPC
0.70
ClinPred
0.047
T
GERP RS
5.6
PromoterAI
-0.032
Neutral
Varity_R
0.25
gMVP
0.81
Mutation Taster
=11/89
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34819316; hg19: chr15-48500263; COSMIC: COSV57708605; COSMIC: COSV57708605; API